Skip to content
10-Q

Quarterly Report

DIAMEDICA THERAPEUTICS INC. DMAC

0001437749-25-034469

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 52.08M sh
Capex Q3 2025 · Sep 30, 2025 $34K
Capex Q3 2025 · Sep 30, 2024 $18K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$21.3M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$15.64M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.33M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.03M
Stockholders Equity Q3 2025 · Sep 30, 2025 $51.62M
Stockholders Equity Q3 2025 · Jun 30, 2025 $27.17M
Stockholders Equity Q3 2025 · Mar 31, 2025 $33.95M
Stockholders Equity Q3 2025 · Dec 31, 2024 $40.72M
Stockholders Equity Q3 2025 · Sep 30, 2024 $47.96M
Stockholders Equity Q3 2025 · Jun 30, 2024 $53.42M
Stockholders Equity Q3 2025 · Mar 31, 2024 $46.35M
Stockholders Equity Q3 2025 · Dec 31, 2023 $51.06M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.39M
Current Assets Q3 2025 · Sep 30, 2025 $56.22M
Current Assets Q3 2025 · Dec 31, 2024 $44.61M
Total Assets Q3 2025 · Sep 30, 2025 $57.05M
Total Assets Q3 2025 · Dec 31, 2024 $46.35M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.17
Eps Basic Q3 2025 · Sep 30, 2025 −$0.53
Eps Basic Q3 2025 · Sep 30, 2024 −$0.15
Eps Basic Q3 2025 · Sep 30, 2024 −$0.42
Sga Expense Q3 2025 · Sep 30, 2025 $2.6M
Sga Expense Q3 2025 · Sep 30, 2025 $7.27M
Sga Expense Q3 2025 · Sep 30, 2024 $1.9M
Sga Expense Q3 2025 · Sep 30, 2024 $5.68M
Rd Expense Q3 2025 · Sep 30, 2025 $6.44M
Rd Expense Q3 2025 · Sep 30, 2025 $17.92M
Rd Expense Q3 2025 · Sep 30, 2024 $4.98M
Rd Expense Q3 2025 · Sep 30, 2024 $12.59M
Net Income Q3 2025 · Sep 30, 2025 −$8.62M
Net Income Q3 2025 · Sep 30, 2025 −$24.03M
Net Income Q3 2025 · Jun 30, 2025 −$7.7M
Net Income Q3 2025 · Mar 31, 2025 −$7.71M
Net Income Q3 2025 · Sep 30, 2024 −$6.27M
Net Income Q3 2025 · Sep 30, 2024 −$16.54M
Net Income Q3 2025 · Jun 30, 2024 −$5.12M
Net Income Q3 2025 · Mar 31, 2024 −$5.15M
Operating Income Q3 2025 · Sep 30, 2025 −$9.03M
Operating Income Q3 2025 · Sep 30, 2025 −$25.18M
Operating Income Q3 2025 · Sep 30, 2024 −$6.88M
Operating Income Q3 2025 · Sep 30, 2024 −$18.26M